Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction

Background— Patients with severe aortic stenosis and reduced left ventricular ejection fraction (LVEF) have a poor prognosis with conservative therapy but a high operative mortality when treated surgically. Recently, transcatheter aortic valve implantation (TAVI) has emerged as an alternative to surgical aortic valve replacement (SAVR) for patients considered at high or prohibitive operative risk. The objective of this study was to compare TAVI and SAVR with respect to postoperative recovery of LVEF in patients with severe aortic stenosis and reduced LV systolic function. Methods and Results— Echocardiographic data were prospectively collected before and after the procedure in 200 patients undergoing SAVR and 83 patients undergoing TAVI for severe aortic stenosis (aortic valve area ≤1 cm2) with reduced LV systolic function (LVEF ≤50%). TAVI patients were significantly older (81±8 versus 70±10 years; P<0.0001) and had more comorbidities compared with SAVR patients. Despite similar baseline LVEF (34±11% versus 34±10%), TAVI patients had better recovery of LVEF compared with SAVR patients (&Dgr;LVEF, 14±15% versus 7±11%; P=0.005). At the 1-year follow-up, 58% of TAVI patients had a normalization of LVEF (>50%) as opposed to 20% in the SAVR group. On multivariable analysis, female gender (P=0.004), lower LVEF at baseline (P=0.005), absence of atrial fibrillation (P=0.01), TAVI (P=0.007), and larger increase in aortic valve area after the procedure (P=0.01) were independently associated with better recovery of LVEF. Conclusion— In patients with severe aortic stenosis and depressed LV systolic function, TAVI is associated with better LVEF recovery compared with SAVR. TAVI may provide an interesting alternative to SAVR in patients with depressed LV systolic function considered at high surgical risk.

[1]  G. Gravlee.  Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction , 2011 .

[2]  M. Cheitlin.  Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction , 2011 .

[3]  Rüdiger Lange,et al.  Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement , 2010, Heart.

[4]  B. Zagorski,et al.  Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier-Edwards pericardial valve with the Toronto Stentless Porcine Valve. , 2010, The Journal of thoracic and cardiovascular surgery.

[5]  Fabian Nietlispach,et al.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.

[6]  Jeroen J. Bax,et al.  Comparison of Aortic Root Dimensions and Geometries Before and After Transcatheter Aortic Valve Implantation by 2- and 3-Dimensional Transesophageal Echocardiography and Multislice Computed Tomography , 2010, Circulation. Cardiovascular imaging.

[7]  D. Adams,et al.  Comparison of the results of aortic valve replacement with or without concomitant coronary artery bypass grafting in patients with left ventricular ejection fraction < or =30% versus patients with ejection fraction >30%. , 2009, The American journal of cardiology.

[8]  F. Mohr,et al.  Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.

[9]  M. Kamler,et al.  Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. , 2009, The Annals of thoracic surgery.

[10]  Philippe Pibarot,et al.  Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. , 2009, Journal of the American College of Cardiology.

[11]  P. Pibarot,et al.  Prosthetic Heart Valves Selection of the Optimal Prosthesis and Long-Term Management , 2009 .

[12]  P. Varadarajan,et al.  Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. , 2008, The Annals of thoracic surgery.

[13]  H. Baumgartner,et al.  Predictors of Outcomes in Low-Flow, Low-Gradient Aortic Stenosis: Results of the Multicenter TOPAS Study , 2008, Circulation.

[14]  T. Sundt,et al.  Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? , 2008, The Journal of thoracic and cardiovascular surgery.

[15]  Mirko Doss,et al.  Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.

[16]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[17]  J. Dunning,et al.  Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. , 2007, The Annals of thoracic surgery.

[18]  Alexander Kulik,et al.  Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression. , 2006, The Journal of thoracic and cardiovascular surgery.

[19]  C. Tribouilloy,et al.  Influence of Preoperative Left Ventricular Contractile Reserve on Postoperative Ejection Fraction in Low-Gradient Aortic Stenosis , 2006, Circulation.

[20]  Hans Ackermann,et al.  Stentless bioprostheses improve postoperative coronary flow more than stented prostheses after valve replacement for aortic stenosis. , 2006, The Journal of thoracic and cardiovascular surgery.

[21]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[22]  H. Baumgartner,et al.  Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study , 2006, Circulation.

[23]  V. Kytö,et al.  Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia. , 2005, The Annals of thoracic surgery.

[24]  Alain Cribier,et al.  Acute Improvement in Global and Regional Left Ventricular Systolic Function After Percutaneous Heart Valve Implantation in Patients With Symptomatic Aortic Stenosis , 2004, Circulation.

[25]  G. Biondi-Zoccai,et al.  Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  Philippe Pibarot,et al.  Impact of Valve Prosthesis-Patient Mismatch on Short-Term Mortality After Aortic Valve Replacement , 2003, Circulation.

[27]  C. Tribouilloy,et al.  Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.

[28]  Dudley J Pennell,et al.  Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis , 2003, Circulation.

[29]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  M. Lauer,et al.  Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. , 2002, Journal of the American College of Cardiology.

[31]  P. Pibarot,et al.  Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. , 2000, Journal of the American College of Cardiology.

[32]  I. Kronzon,et al.  Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. , 2000, Archives of internal medicine.

[33]  A. Tajik,et al.  Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. , 2000, Circulation.

[34]  P. Pibarot,et al.  Usefulness of the indexed effective orifice area at rest in predicting an increase in gradient during maximum exercise in patients with a bioprosthesis in the aortic valve position. , 1999, The American journal of cardiology.

[35]  R. A. Johnson,et al.  Cardiomyopathic syndrome due to coronary artery disease. I: Relation to angiographic extent of coronary disease and to remote myocardial infarction. , 1977, British heart journal.